Drug profile · INN
azatadine maleate
OPTIMINE
azatadine maleate (OPTIMINE) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — azatadine maleate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
azatadine maleate (OPTIMINE) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is azatadine maleate?
azatadine maleate (OPTIMINE) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for azatadine maleate?
OPTIMINE is a marketed brand name for azatadine maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of azatadine maleate?
azatadine maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.